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Neuroimmunomodulation by regional and general
anaesthesia
Abstract
Background and Purpose: This review presents the detailed immuno-
logical impact of neural variables, including stress, on specific cellular and
molecular events that that take place over the full (time course) duration of
autoimmune, inflammatory, allergic and infectious diseases.
Materials and Methods: A comprehensive search of literature from ma-
jor injury (serious traumatic injury and major burns) to major surgical pro-
cedures that often lead to severe immunosuppression, which contributes to
delayed wound healing, infectious complications and, in some cases, to sep-
sis, the most common cause of late death after trauma.
Results: Strong stimulation of the SNS and the HPA axis correlates with
the severity of both cerebral and extracerebral injury and an unfavourable
prognosis. The suppressed cellular immunity is associated with diminished
production of IFN-g and IL-12 and increased production of IL-10 – Th2
shift. Disbalance in relations Th1 and Th2 cytokine secreted by the T lym-
phocytes is considered the main difference between general and regional an-
aesthesia.
Conclusions: Considerable in-vitro data and in-vivo animal studies sug-
gest that three factors associated with cancer surgery impair cellular immu-
nity: the stress response to tissue injury, general anaesthesia and opioid anal-
gesia. Regional analgesia decreases the neuroendocrine stress response to
surgical tissue injury, eliminates or reduces the need for general anaesthesia
and minimises opioid requirement. Thus cancer recurrence is lower after
surgery with regional anaesthesia/analgesia than after surgery with general
anaesthesia and opioid analgesia.
INTRODUCTION
Major injury (serious traumatic injury and major burns) or majorsurgical procedures often lead to severe immunosuppression
which contributes to delayed wound healing, infectious complications
and, in some cases, to sepsis, the most common cause of late death after
trauma (1). The effect of anaesthesia on endocrine function is closely
related to the actual stress concept based on studies by Cannon and
Selye (2). Cannon described the role of catecholamines in stress and
characterised the fight-flight reaction (2). Selye emphasised the role of
the adrenocortical reaction defining the »general adaptation syndrome«,
which evolves in three stages (»alarm reaction«, »stage of resistance«,
»stage of exhaustion«) (2). Anaesthesia can influence the stress re-
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Overview
(general anaesthesia) or peripheral interactions with the
endocrine system (etomidate). Up to now, a total periph-
eral blockade of the nociceptive system is impossible, due
to surgical technique (destruction of nerve fibres) and
release of mediator substances. Spinal and epidural an-
aesthesia alone as well as in combination with general
anaesthesia can reduce the endocrine stress response
more than necessary. This is due to the sympathetic
blockade, combined with an afferent blockade of central
cord fibres which modulate the pituitary-adrenocortical
system. Only few data are available concerning the stress
response during infiltration anaesthesia or nerve block,
but additional sedation seems to be beneficial (2).
The stress response, anaesthesia and
surgical outcome
The stress response is the term given to the hormonal
and metabolic changes which follow injury or trauma
(3). This is part of the systemic reaction to injury which
encompasses a wide range of endocrinological, immuno-
logical and haematological effects (Table 1) (4).
The hypothalamic-pituitary axis and the sympathetic
nervous system are activated by afferent nerve input,
both somatic and autonomic, from the area of trauma or
injury. These impulses travel along sensory nerve roots
through the dorsal root of the spinal cord, up the spinal
cord to the medulla to activate the hypothalamus (2).
The changes in pituitary secretion have secondary effects
on hormone secretion from target organs (Table 2) (5).
There is a failure of the normal feedback mechanisms
of the control of hormone secretion. For example, en-
hanced cortisol secretion fails to inhibit further produc-
tion of adrenocorticotropic hormone (ACTH) (6/4). In
general, there is release of catabolic hormones such as the
catecholamines and pituitary hormones whereas anabo-
lic hormones such as insulin and testosteron are sup-
pressed.
The overall metabolic effect of the hormonal changes
is increased catabolism which mobilises substrates to
provide energy sources and a mechanism to retain salt
and water and maintain fluid volume and cardiovascular
homeostasis (7).
The stress response and immunology
The immunological effects of stress are mediated by
cytokines, which are a group of low-molecular weight
proteins which include the interleukins and interferons.
They are produced from activated leucocytes, fibroblasts
and endothelial cells as an early response to tissue injury
and have a major role in mediating immunity and in-
flammation (3). The cytokines act on surface receptors
on many different target cells and their effects are pro-
duced ultimately by influencing protein synthesis within
these cells. They have local effects of mediating and
maintaining the inflammatory response to tissue injury,
and also initiate some systemic changes which occur. Af-
ter major surgery, the main cytokines released are inter-
leukin-1 (IL-1), tumour necrosis factor – a (TNF-a) and
inteleukin-6 (IL-6) (3, 8, 9). The initial reaction is the re-
lease of IL-1 and TNF-a from activated macrophages
and monocytes in the damaged tissues. This stimulates
the production and release of more cytokines, in particu-
lar, IL-6, the main cytokine responsible for inducing the
systemic changes known as the acute phase response
(Table 3) (4).
There are also interactions between the immune sys-
tem and the neuroendocrine system. The cytokines IL-1
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TABLE 2
Hormonal changes during surgery (5).
Pituitary Adrenal Pancreatic Others









Unchanged secretion Thyroid stimulating hormone (TSH)
Luteinizing hormone (LH)
Follicle stimulating hormone (FSH)




Systemic responses to surgery (4).









and IL-6 can stimulate secretion of ACTH and subse-
quently increase the release of cortisol (5). A negative
feedback system exists, so that glucocorticoids inhibit
cytokine production. The cortisol response to surgery is
sufficient to depress IL-6 concentrations.
The stress response and anaesthesia
Anaesthesia may indirectly affect the immune system
of surgical patients by modulating neurohormonal stress
response. In particular, regional anaesthesia attenuates
this stress response and the associated effect on cellular
and humoral immunity (10). Additionally, anaesthetics
may directly affect the functions of immune-competent
cells. Mostly they have immunosuppressive effects which
may be particularly important in the intensive care unit
when anaesthetics are used as long-term sedatives. On
the other hand, anti-inflammatory effects of anaesthetics
may be therapeutically beneficial in distinct situations
such as those involving ishaemia/reperfusion injury or
systemic inflammatory response syndrome (11).
The stress response and outcome
There has been a great deal of interest in modification
of stress response with respect to the potential beneficial
effects on surgical outcome. The extent to which the re-
sponses are modified depends on the choice of the anal-
gesic techniques used. Inhibition of stress response is
greatest with neural blockade (epidural) (with) by local
anaesthetics (8, 9). These changes in the immune system
are irrelevant in young and healthy patients, but in high
risk patients can potentiate cardiovascular complications,
infection, MOF (multiorgan failure) and higher inci-
dence of metastatic diseases.
Most current data support the notion that acute in-
flammation triggered by tumour-infiltrating host leuko-
cytes does not exert normal immunoprotective mecha-
nisms that lead to eradication of the evolving cancer
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Figure 1. A cytokine-mediated link between innate immunity, inflammation and cancer. Take from LIN W W, KARIN M 2007.
TABLE 3
Features of the acute phase response (4).
Fever
Granulocytosis




Changes in serum concentrations in transport proteins
Increase in ceruloplasmin
Decrease in transferin, albumin and a-2
macroglobulin
Changes in serum concentrations in divalent cations
Copper increases
Zinc and iron decrease
(antitumour immunity). Instead, excessively and chroni-
cally produced proinflammatory mediators are thought
to contribute to tumour promotion and progression (Fig-
ure 1) (12). Thus, cancer can be promoted and/or exac-
erbated by inflammation and infection. A key molecular
link between inflammation and tumour promotion and
progression is provided by the inhibitor of NF-kB kinase/
NF-kB (IKK/ NF-kB) signalling pathway, which is acti-
vated by many proinflammatory cytokines (12).
Clinical evaluation and research
Pain, surgical stress, tissue injury and invasive mi-
cro-organisms are known to modulate complex immune
responses in patients undergoing major surgery, which
can lead to subsequent increased susceptibility to postop-
erative infections. Anaesthetics may influence the im-
mune response indirectly through modulation of the
neurohumoral response or directly by acting on immune
competent cells. General anaesthesia accompanied by
surgical stress is considered to suppress immunity, pre-
sumably by directly affecting the immune system or acti-
vating the hypothalamic-pituitary-adrenal axis and the
sympathetic nervous system. Along with stress such as
surgery, blood transfusion, hypothermia, hyperglycae-
mia, and postoperative pain, anaesthetics per se are asso-
ciated with suppressed immunity during perioperative
periods because all anaesthetics have direct suppressive
effects on cellular and neurohumoral immunity (through)
by influencing the functions of immunocompetent cells
and inflammatory mediator gene expression and secre-
tion. Particularly in cancer patients, immunosuppression
attributable to anaesthetics, such as the dysfunction of
natural killer cells and lymphocytes, may accelerate the
growth and metastases of residual malignant cells, thereby
worsening prognoses. Alternatively, the anti-inflamma-
tory effects of anaesthetics may be beneficial in (distinct)
certain situations involving ischemia and reperfusion in-
jury or the systemic inflammatory response syndrome
(SIRS) (13, 14). Immunosuppressive effects may be par-
ticularly relevant in the intensive care unit when anaes-
thetics are used as long-term sedatives and evidence of
infectious complications (9).
Spinal and epidural anaesthesia alone as well as in
combination with general anaesthesia and optimum
postoperative analgesia can reduce the endocrine stress
response more than necessary. This is due to the sympa-
thetic blockade, combined with an afferent blockade of
central cord fibres which modulate the pituitary-adreno-
cortical system.
Surgery remains the most effective treatment for most
cancers, although it is usually associated with systemic
release of tumour cells, in addition, pre-existing scattered
micrometastases commonly remain. Whether minimal
residual disease succeeds in establishing itself as recur-
rence or metastases is primarily a function of the host de-
fence. In practice, the immune system frequently fails to
neutralise remaining malignant tissues. Considerable in
vitro data and in vivo animal studies suggest that three
factors associated with cancer surgery impair cellular im-
munity: the stress response to tissue injury, general
anaesthesia and opioid analgesia. Regional analgesia de-
creases the neuroendocrine stress response to surgical tis-
sue injury, eliminates or reduces the need for general an-
aesthesia, and minimises opioid requirement. I therefore
propose the hypothesis that cancer recurrence is lower
after surgery with regional anaesthesia/analgesia than
after surgery with general anaesthesia and opioid anal-
gesia. Confirming this hypothesis would indicate that a
minor modification to anaesthetic management reduces
the risk of cancer recurrence (15).
Surgery of breast cancer is the primary and most ef-
fective treatment, but minimal residual disease is proba-
bly unavoidable. Whether residual disease results in clin-
ical metastases depends on numerous factors, including
anti-tumour cell mediated immunity and angiogenic and
growth signals in sites of residual disease. At least three
perioperative factors adversely affect these: 1) the neuro-
endocrine stress response to surgery, 2) volatile anaes-
thetics and 3) opioids. Retrospective studies in humans
also suggest that regional analgesia may reduce recur-
rence risk after cancer surgery. Sessler et al. (16) reports
that local or metastatic recurrence after breast cancer sur-
gery is lower in patients randomised to paravertebral or
high-thoracic epidural analgesia combined with sedation
or light anaesthesia than in patients given intraoperative
volatile anaesthesia and postoperative opioid analgesia.
They (enrolling) examined 1100 patients over 5 years and
confirmed that a small modification to anaesthetic man-
agement, one that can be implemented with little risk or
cost, will reduce the risk of cancer recurrence – a compli-
cation that is often ultimately lethal (16).
Biki B at al. (17) evaluated prostate cancer recurrence
in patients who received either general anaesthesia with
epidural anaesthesia/analgesia or general anaesthesia
with postoperative opioid analgesia. They concluded that
open prostatectomy surgery with general anaesthesia,
substituting epidural analgesia for postoperative opioids,
was associated with substantially less risk of biochemical
cancer recurrence (17).
Many studies have shown that regional anaesthesia
improves postoperative outcome and particularly lessens
infection by attenuating perioperative immunosuppres-
sion related to the stress response to surgery and general
anaesthesia (8). However, it remains to be determined
whether regional anaesthesia improves oncologic out-
come after surgery. Wada H et al.(18) showed that the
addition of spinal block to sevoflurane general anaesthesia
reduces the promotion of tumour metastasis. C57BL/6
mice were subjected to laparotomy during sevoflurane
general anaesthesia alone or combined with spinal block
achieved with bupivacaine (5 microg) and morphine
(1.25 microg). Sevoflurane anesthesia plus spinal block
significantly reduced this increase to 19.8 +/- 9. The in
vitro killer activity of liver mononuclear cells against EL4
cells decreased from 32.7% (control) and 29.4% (sevo-
flurane alone) to 18.5% after sevoflurane plus laparotomy,
and the addition of spinal block increased activity to
26.6%. The interferon-gamma/interleukin-4 ratio decreas-
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ed from 89.3 (control) and 95.7 (anaesthesia alone) to
15.7 after sevoflurane plus laparotomy, and the addition
of spinal block increased the ratio to 46.5. The addition
of spinal block to sevoflurane general anaesthesia accom-
panying surgery attenuates the suppression of tumori-
cidal function of liver mononuclear cells, presumably by
preserving the T helper 1/T helper 2 (Th1/Th2) balance,
and thereby reduces the promotion of tumour metastasis
(18).
The immune response (measured by a variety of pa-
rameters) was examined in patients undergoing trans-
urethral resection of the prostate (TURP) for benign dis-
ease. A significant reduction in lymphocyte numbers and
in the response of lymphocytes to the mitogens PPD and
PWM and to histocompatibility antigens in mixed lym-
phocyte culture was seen in patients after TURP under
general anaesthetic, although minimal changes were found
in patients who had spinal anaesthetic. Cortisol levels
were not elevated in either group after surgery. The
immunodepression occurring after TURP appears to be
due to general anaesthesia rather than the trauma of sur-
gery (19).
Surgical stress and anaesthesia cause immunosup-
pression that may predispose patients to postoperative
infections. T helper lymphocytes play a major role in the
immune response by controlling cell-mediated and hu-
moral immunity. The type of immune response gener-
ated is determined by the differentiation of precursor T
helper cells into Th1 or Th2 cells. Each cell subset secretes
a particular array of cytokines that further augment the
differentiation into that subset. Th1 cells produce inter-
feron gamma and are responsible for cell-mediated im-
munity. Th2 cells produce interleukin-4 and are more
effective in inducing humoral immunity. Cytokine con-
centrations are altered during surgery and anaesthesia,
which may effect Th cell predominance and, therefore,
subsequent immune responses. Le Cras et al. (20) deter-
mined Th1 to Th2 cell ratios in patients undergoing
transurethral resection of the prostate (TURP) using ei-
ther spinal or general anaesthesia. Mononuclear cells
were isolated before anaesthesia, immediately after sur-
gery, and after 24 h from patients undergoing TURP. T
helper cell subsets were quantified by using flow cyto-
metry, and the ratio of Th1 to Th2 cells was calculated.
Results of data suggest that, from an immunological
viewpoint, spinal anaesthesia, but not general anaesthe-
sia, benefits the patient by maintaining Th1 cell numbers,
thereby promoting cellular immunity. Spinal anaesthesia
may result in less immunosuppression after surgery. They
found that the ratio of T helper 1 to T helper 2 cells was
higher in patients undergoing prostate surgery by spinal
rather than general anaesthesia. Th1 cells promote pro-
tective immune responses that may result in fewer post-
operative infections (20).
Cytokines are significant mediators of the immune re-
sponse to surgery and also play a role in parturition. The
study was to investigate the impact of the anaesthetic
technique (spinal and general anaesthesia) for cesarean
section on plasma levels of cytokines IL-6 and TNF-a.
Under the present study design anaesthetic technique
did not affect IL-6 or TNF-a concentrations in partu-
rients undergoing elective cesarean section. Serum IL-6
levels increased 24 h postoperatively independently of
anaesthetic technique (21).
Glial cells and pain
Today, there is a need for development of new agents
and methods for the treatment and prevention of postoper-
ative complications. Attention has recently shifted from
neuronal modulation to the discovery of glial modulating
agents for the treatment of a host of neurodegenerative
diseases, as well as pain.
Glial cells are key neuromodulatory, neurotrophic and
neuroimmune elements in the CNS. Glial cells, including
resident microglia, perivascular microglia, astrocytes and
oligodendrocytes constitute over 70% of the total cell popu-
lation in the brain and spinal cord. Microglia, cells of
monocytic origin, are the macrophages of the brain and
the first cell type to respond to CNS injury (22). The ini-
tial signal that triggers microglial reactivity is not fully un-
derstood; however, neuronal depolarization and extracel-
lular ion changes following nerve injury may be major
stimuli. Alternatively, neuronal signals such as nitric ox-
ide (NO) or pro-inflammatory cytokines may induce this
reactivity.
Microglia both release and respond to several cytokines
including interleukin (IL)-1, IL-6, tumour necrosis factor
(TNF-a) and interferon-a, all of which are instrumental in
astrocytic reactivity, induction of cellular adhesion molecule
expression and recruitment of T-leukocytes into the le-
sion. In addition, microglia may act as cytotoxic effector
cells by releasing proteases, reactive oxygen intermediates
and NO. Perivascular microglia are CNS antigen-present-
ing cells and play an important role in the communication
of the CNS with the peripheral immune system, espe-
cially in pathological conditions (22) such as perioperative
pain. Astrocytic changes in response to injury include pro-
liferation, hypertrophy, and over-expression of glial fibril-
lary acidic protein (GFAP). Spinal GFAP increases follow-
ing peripheral nerve injury (22).
The goal of further clinical studies must be to establish
the immunomodulating properties of individual anaes-
thetic agents so that selection can be tailored to the individ-
ual patient’s pre-operative immune status and intraope-
rative course (23, 24), with regard to long-term mortality,
morbidity, and the optimal prognosis.
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